Shares of pharmaceutical giant Pfizer (NYSE: PFE) are currently trading below $25, marking a decline of approximately 60% ...

It's quite possible for the new year to fulfill this ambitious name. Investing $122,100 in these three high-yield dividend ...

This makes Pfizer a potentially cheap stock to buy while collecting a solid dividend. It's generated about $14 billion in ...

The price hikes come even as the Trump administration pressures pharmaceutical companies to lower costs for patients and ...

The costs of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the ...

According to healthcare research firm 3 Axis Advisors, drugmakers are planning to raise U.S. prices on medications including ...

How $2,670 split across three durable high-yield stocks can generate $300 in annual dividends without risky payouts.

GSK (GSK) and other leading drugmakers plans to raise prices of as many as 350 medicines next year, with a median hike of ...

More medicines are slated for price hikes in 2026, with increases tracking around recent inflation levels. ・Only a few drugs ...

Drugmakers plan to raise U. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and ...

On December 16, Pfizer Inc. (NYSE:PFE) said the next few years are expected to be bumpy, starting in 2026. The company ...

Medicine is expensive and only seems to get more so every year. But this doesn’t have to be inevitable. The reason patients ...